Chi Ming Cheung

Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong.

Part of Liuzhou OVM Machinery Co. Ltd., OVM International Development Co. Ltd. is a Chinese company that retails building equipment. The company is based in Hong Kong, Hong Kong.

The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom.

Tomoike Industrial (HK) Ltd. engages in the provision of office automation equipment and liquid crystal display related products. It also offers optical sheet, electrical insulating material processed products, and print products. The firm also engages in pressing, assembly, and manufacture and sale of electromagnetic shield parts. The company was founded on April 23, 1991 and is headquartered in Hong Kong.